Keyphrases
COVID-19 Patients
100%
Cobicistat
100%
Lopinavir
100%
Darunavir
100%
Propensity Score
25%
Cardiovascular Disease
12%
COVID-19
12%
Non-associated
12%
Large Cohort
12%
Italian Patients
12%
Clinical Outcomes
12%
Medical Records
12%
Risk of Death
12%
Multicenter Observational Study
12%
In-hospital Mortality
12%
Increased Mortality
12%
Protease Inhibitors
12%
Young Men
12%
Kidney Disease
12%
Italian Hospital
12%
Therapeutic Agents
12%
Cox Proportional Hazards Model
12%
Pulmonary Disease
12%
C-reactive Protein Level
12%
Time-to-event Analysis
12%
Death Rate
12%
Elderly Inpatients
12%
Clinical Measures
12%
High Severity
12%
E-value
12%
Hypertension Disease
12%
Real-life Setting
12%
Multinomial
12%
COVID-19 Severity
12%
Inverse Probability of Treatment Weighting
12%
COVID-19 Drugs
12%
Pre-existing Conditions
12%
Nursing and Health Professions
Darunavir
100%
Cobicistat
100%
Lopinavir Plus Ritonavir
100%
Propensity Score
25%
C Reactive Protein
12%
Drug Therapy
12%
Mortality Rate
12%
Hospital Mortality
12%
Cardiovascular Disease
12%
Kidney Disease
12%
Medical Record
12%
Proteinase Inhibitor
12%
Proportional Hazards Model
12%
Lung Disease
12%
E-Value
12%
Darunavir Plus Ritonavir
12%
Pharmacology, Toxicology and Pharmaceutical Science
Cobicistat
100%
Darunavir
100%
Lopinavir Plus Ritonavir
100%
Observational Study
25%
Kidney Disease
12%
C Reactive Protein
12%
Lung Disease
12%
Mortality Rate
12%
Hospital Mortality
12%
Proteinase Inhibitor
12%
Darunavir Plus Ritonavir
12%
Cardiovascular Disease
12%